Besides the well-known positive effects on skeletal homeostasis and bone metabolism, growing evidence highlights the importance of vitamin D also in other many extra-skeletal districts; the articles published in this Research Topic confirm this observation in both adult and pediatric populations, spanning different conditions from inflammation and infectious diseases, obesity, and diabetes, to neurological disorders, gastrointestinal conditions, neurological disorders, cardiovascular health, and malignancies (see Table 1). This fact contributes to the increasing attention toward the measurement of serum 25(OH)D (main circulating form and recognized biomarker of vitamin D status) in laboratory medicine as well as the requirements of accuracy and speed of testing. However, despite the growth and refinement of analytical methods, the measurement of vitamin D still represents a challenge; immunoanalytical techniques still retain great variability in inter-laboratory comparisons, whereas mass spectrometry presents many different difficulties (e.g., costs, time, and complexity, matrix effects, derivatization step) (1). Interestingly, other vitamin D metabolites may have biological roles, and are expected to be assessed in the serum in the future (2).
Table 1.
Title | Authors | Setting | Patients | Results |
---|---|---|---|---|
No causal relationship between serum vitamin D levels and alcoholic liver disease: a two-sample bidirectional Mendelian randomization study | Wu H, Wu L, Zhang Q, Li C, Li HY, Zhang BF. | Alcoholic liver disease (ALD) | Adults | No reciprocal causal link between serum VD and ALD susceptibility |
Vitamin D in tuberous sclerosis complex-associated tumors | Tatsuro Nobutoki | Tuberous sclerosis complex-associated tumors |
Children | Review discussing the possible role of 1,25VD in pediatric tuberous sclerosis complex-associated tumors, and the significance of vitamin D signaling as adjuvant or alternative drug target |
Vitamin D status, vitamin D receptor, CYP2R1, and CYP24A1 profiles in children | Iriani A, Rachman A, Fatina MK, Gemilang RK, Trisnandi A, Muskananfola FV, Nugraha MFI. | Vitamin D status | Children | VD level is reduced by aging in children; VDR level is also found different based on VD status |
Explorative case control study on the associations of serum vitamin D3, folic acid and vitamin B12 levels on Kawasaki disease and coronary artery lesions | Chen Y, Liu X, Li B, Li J, Meng L, Ye C, Han L, Li H, Deng LL, Su Z, Zhang X. | Kawasaki disease and coronary artery lesions |
Children | Folic acid and VD3 were significantly reduced in children with KD, especially in those with coronary artery lesions |
Changes in vitamin D status among adults from the COVID-19 pandemic to post-pandemic normality | Chen Y, Kong G. | COVID-19 | Adults | COVID-19 pandemic significantly impacted VD status, leading to an increased prevalence of deficiency, especially among males |
Nonlinear correlation and mediation effects between serum 25-hydroxyvitamin D levels and all-cause mortality in COPD patients | Jiang Q, Jiang Y, Ma Z, Huang J, Li Y. | COPD | Adults | High prevalence of low VD in COPD patients; non-linear association between serum 25(OH)D concentration and all-cause mortality (better survival above 63.40 nmol/L), with VD mediating role between dietary inflammation and mortality (mediation analysis) |
The effects of vitamin D supplementation on serum lipid profiles in people with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials | Lu Q, Liang Q, Xi Y. | Type 2 diabetes | Adults | The meta-analysis evidenced the benefit of VD supplementation in improving serum HDL and TG but not in LDL and TC levels |
Associations of vitamin D status with all-cause and cause-specific mortality in long-term prescription opioid users | Dai S, Wu J, Wang P, Hu Z. | Opioid users | Adults | Non-linear association between serum 25(OH)D concentration and all-cause mortality |
Implications of vitamin D levels or status for mortality in rheumatoid arthritis: analysis of 2001-2018 data from the National Health and Nutrition Examination Survey | Feng Y, Zhu P, Dandan Y, Wang X, Chen C, Zhang Z, Tian Y, Wang J, Liu S, Li J, Meng D, Wang K. | Rheumatoid arthritis (RA) | Adults | A significant negative correlation between 25(OH)D levels and overall mortality in individuals with RA, especially for mortality related to heart disease and cancer |
Serum 25-hydroxyvitamin D concentrations and their impact on all-cause mortality in Parkinson's disease: insights from National Health and Nutrition Examination Survey 1999–2020 data | Yong Y, Dong H, Zhou Z, Zhu Y, Gu M, Li W. | Parkinson's disease | Adults | Non-linear association between serum 25(OH)D concentration and all-cause mortality (optimal survival rates at 75–100 nmol/L) |
The complex relationship between vitamin D and kidney stones: balance, risks, and prevention strategies | Zhang F, Li W. | Kidney stones | Adults | The review discusses actual evidence on the relationship between vitamin D status and kidney stone risk, and the role of vitamin D supplementation for preventing and treating kidney stones. |
Factors associated with vitamin D deficiency in health care workers exposed to SARS-CoV-2: a cross-sectional study | Villasis-Keever MA, Zurita-Cruz JN, Garduño-Espinosa J, López-Alarcón M, Barradas Vázquez AS, Miranda-Novales MG, Parra-Ortega I, López-Martinez B, García H, Klünder-Klünder M. | COVID-19 | Adults | High prevalence of VD deficiency in Mexican health care workers exposed to SARS-CoV-2, related to both personal health factors and occupational low VD values is high among health care workers, and TD2 was a significant risk factor associated with these values. conditions (e.g. T2D) |
The relationship between physical activity levels and serum vitamin D levels varies among children and adolescents in different age groups | Ouyang S, Li Q, Liu Z, Yin Y. | Physical activity (PA) | Children and adolescents | PA and VD varies according to sex and age, with sun exposure level and BMI affecting PA/VD relationship |
Comparative Analysis of COVID-19 Responses in Japan and Africa: Diet, Phytochemicals, Vitamin D, and Gut Microbiota in Reducing Mortality -A Systematic Review and Meta-Analysis | Santa K, Tamaki R, Watanabe K, Nagaoka I. | COVID-19 | Adults | Blood vitamin D levels are associated with COVID-19 mortality |
Vitamin D Deficiency in Non-scarring and Scarring Alopecias: A Systematic Review and Meta-Analysis | Yongpisarn T, Tejapira K, Kunlawat Thadanipon K, Suchonwanit P. | Alopecias | Adults | Patients with non-scarring alopecia have insufficient serum VD level and increased incidence of vitamin D deficiency |
Cardiometabolic factors and vitamin D deficiency in pediatric patients with chronic kidney disease | Fayoumi T, Gari A, Alarawi M, Almutairi S, Shalabi BH, Safdar O, Al Kadi H. | Chronic kidney disease (CKD) |
Children | Children with CKD and low VD ( ≤ 41.9 nmol/L) presented a more adverse cardiometabolic risk profile |
Relationship between Serum Vitamin D Levels and the Atherogenic Index of Plasma (AIP): A Study Based on NHANES Database 2011–2018 | Hu T, Zhang Y, Chen Z, Su J. | Risk of atherosclerosis | Adults | A significant negative correlation and saturation effect was found between serum vitamin D and the atherogenic index of plasma (AIP) in a large general adult population (n = 9637) from the NHANES |
VD, vitamin D; VDR, vitamin D receptor; T2D, type 2 diabetes; BMI, body mass index; COPD, chronic obstructive pulmonary disease; KD, Kawasaki disease.
In any case, at present the high prevalence of vitamin D deficiency is a worldwide major public sanitary issue in every stage of life, including children and adolescents, where an inadequate status can have implications on future health and wellbeing (3, 4). In this regard, as many as five contributions focusing on different children issues are included in this Research Topic (see Table 1). Moreover, available dosing recommendations for vitamin D supplementation may considerably vary in the literature depending on the clinical setting and specific cohort evaluated. Importantly, there is still no international general consensus on how to define an optimal vitamin D status, mainly defined based on the inverse relationship of parathyroid hormone and 25(OH)D. For it concerns bone health, the Endocrine Society defines as adequate serum 25(OH)D levels higher than 75 nmol/L (30 ng/mL) and values higher than 50 nmol/L (20 ng/mL) as deficient (5); instead, the Institute of Medicine (IOM, now National Academy of Medicine) definition suggests vitamin D sufficiency for values higher than 50 nmol/L (20 ng/mL), insufficiency between 30 and 50 nmol/L (12–20 ng/mL); deficiency for levels lower than 30 nmol/L (12 ng/mL) (6). In addition, differences may also be due to methodological issues (e.g., seasonal sampling, variability in the vitamin D assays), characteristics of the studied populations, (e.g., age, sex, and calcium intake), and life-style habits (physical activity, outdoor activities, and sun exposure) (1). Moreover, the majority of evidence derived from studies conducted in adults, and even the threshold used to define vitamin D deficiency or insufficiency may not be appropriate when applied to children and/or adolescents. Indeed, currently, there are no specific guidelines and no clear consensus on targets for optimal vitamin D status and supplementation in most extra-skeletal conditions (1). Thus, for non-classical actions, more research is needed concerning the optimal 25(OH)D levels to maintain and clarify the suitability of 25(OH)D reference levels (in turn useful to decide the recommended vitamin D intake to maintain most people above this threshold, providing adequacy) and the role of vitamin D as key indicator of health in different clinical settings. We hope that manuscripts included in this Research Topic, which highlight the role and levels of vitamin D in different pathophysiological conditions, may contribute to the actual discussion in this field and may be appreciated by readers of Frontiers in Nutrition, facilitating further studies stimulated by the data reported and by the many challenges still to be solved in this important research area.
Author contributions
CV: Conceptualization, Writing – original draft.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
- 1.Della Nera G, Sabatino L, Gaggini M, Gorini F, Vassalle C. Vitamin D determinants, status, and antioxidant/anti-inflammatory-related effects in cardiovascular risk and disease: not the last word in the controversy. Antioxidants (Basel). (2023) 12:948. 10.3390/antiox12040948 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Slominski AT, Tuckey RC, Jetten AM, Holick MF. Recent advances in vitamin D biology: something new under the sun. J Investig Dermatol. (2023) 143:2340–2. 10.1016/j.jid.2023.07.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Cui A, Zhang T, Xiao P, Fan Z, Wang H, Zhuang Y. Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: a pooled analysis of 7.9 million participants. Front Nutr. (2023) 10:1070808. 10.3389/fnut.2023.1070808 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Huh SY, Gordon CM. Vitamin D deficiency in children and adolescents: epidemiology, impact and treatment. Rev Endocr Metab Disord. (2008) 9:161–70. 10.1007/s11154-007-9072-y [DOI] [PubMed] [Google Scholar]
- 5.Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. (2011) 96:1911–30. 10.1210/jc.2011-0385 [DOI] [PubMed] [Google Scholar]
- 6.Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. (2011) 96:53–8. 10.1016/j.jada.2011.01.004 [DOI] [PMC free article] [PubMed] [Google Scholar]